/Companies

Electra

South San Francisco, US · Delaware corporation · 46 employees on LinkedIn · 7 known investors

Find your way into Electra

Sign up to see every warm intro you have to Electra

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Electra team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Electra Therapeutics develops antibody therapeutics targeting Signal Regulatory Protein (SIRP) for immunological diseases and cancer treatment. The company explores and validates novel drug targets with a focus on breakthrough therapies addressing underlying disease pathology.

Founders & leadership

ARAdam Rosenthal
Adam RosenthalCEO and Co-Founder2018–2023He founded Star Therapeutics in 2018 and co-founded its affiliated companies, including Vega Therapeutics, serving as CEO of each. Earlier, he was Chief Business Officer at True North Therapeutics, VP and Head of Corporate Development at iPierian, and a project leader at The Boston Consulting Group.
Q(
Quehuong (Kathy) Dong, Pharm.D.Executive
KD
Kathy DongPresident, Chief Executive Officer and DirectorPresident, Chief Executive Officer and Director at Electra Therapeutics

Board

BS
Beth Seidenberg, M.D.Board director
TG
Thomas Geninatti, Ph.D.Board director
CG
Carl Gordon, Ph.D.Board director
MF
Matthew FustBoard director
NS
Nancy Stagliano, Ph.D.Board director

Investors · 7

Reported raises · per SEC filings

Form D private placements

$134.2M disclosed across 1 round · 2025

▶$134.2MraisedOct 2025 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Beth Seidenberg, M.D.Director
  • Thomas Geninatti, Ph.D.Director
  • Matthew FustDirector
  • Carl Gordon, Ph.D.Director
  • Nancy Stagliano, Ph.D.Director
  • Quehuong (Kathy) Dong, Pharm.D.Executive Officer, Director
Offering amount
$184.1M
Amount sold
$134.2M
First sale
Oct 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Electra Therapeutics went on to found or lead other companies.

Related companies · 2

Companies working in the same space as Electra.

In the news

Frequently asked questions

What does Electra do?
Electra Therapeutics develops antibody therapeutics targeting Signal Regulatory Protein (SIRP) for immunological diseases and cancer treatment. The company explores and validates novel drug targets with a focus on breakthrough therapies addressing underlying disease pathology.
Who founded Electra?
Electra was founded by Adam Rosenthal.
Who are Electra's investors?
Electra's investors include HBM Healthcare Investments, HBM Partners, OrbiMed, RA Capital, Westlake Village BioPartners, Kleiner Perkins, NVIDIA.
How much funding has Electra raised?
Electra has disclosed $134.2M raised across 1 round.
Where is Electra headquartered?
Electra is headquartered in South San Francisco, US.